JP7020924B2 - ＩｇＧ４κ／λハイブリッド抗体の検出によってＩｇＧ４関連疾患を検出またはモニタリングする方法 - Google Patents

ＩｇＧ４κ／λハイブリッド抗体の検出によってＩｇＧ４関連疾患を検出またはモニタリングする方法 Download PDF

Info

Publication number
JP7020924B2
JP7020924B2 JP2017568262A JP2017568262A JP7020924B2 JP 7020924 B2 JP7020924 B2 JP 7020924B2 JP 2017568262 A JP2017568262 A JP 2017568262A JP 2017568262 A JP2017568262 A JP 2017568262A JP 7020924 B2 JP7020924 B2 JP 7020924B2
Authority
JP
Japan
Prior art keywords
igg4
light chain
bound
specific
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017568262A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018519525A5 (https=
JP2018519525A (ja
Inventor
ウォリス グレッグ
ハーディング スティーブン
Original Assignee
ザ バインディング サイト グループ リミティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ バインディング サイト グループ リミティド filed Critical ザ バインディング サイト グループ リミティド
Publication of JP2018519525A publication Critical patent/JP2018519525A/ja
Publication of JP2018519525A5 publication Critical patent/JP2018519525A5/ja
Application granted granted Critical
Publication of JP7020924B2 publication Critical patent/JP7020924B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
JP2017568262A 2015-06-29 2016-06-28 ＩｇＧ４κ／λハイブリッド抗体の検出によってＩｇＧ４関連疾患を検出またはモニタリングする方法 Active JP7020924B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1511364.0A GB201511364D0 (en) 2015-06-29 2015-06-29 Method of detecting or monitoring an IgG4-related disease
GB1511364.0 2015-06-29
PCT/GB2016/051939 WO2017001841A1 (en) 2015-06-29 2016-06-28 Method of detecting or monitoring an igg4-related disease by detecting igg4 kappa/lambda hybrid antibodies

Publications (3)

Publication Number Publication Date
JP2018519525A JP2018519525A (ja) 2018-07-19
JP2018519525A5 JP2018519525A5 (https=) 2020-12-03
JP7020924B2 true JP7020924B2 (ja) 2022-02-16

Family

ID=53872357

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017568262A Active JP7020924B2 (ja) 2015-06-29 2016-06-28 ＩｇＧ４κ／λハイブリッド抗体の検出によってＩｇＧ４関連疾患を検出またはモニタリングする方法

Country Status (4)

Country Link
EP (1) EP3314267A1 (https=)
JP (1) JP7020924B2 (https=)
GB (1) GB201511364D0 (https=)
WO (1) WO2017001841A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114324884A (zh) * 2020-09-30 2022-04-12 南京金斯瑞生物科技有限公司 一种不依赖于抗体类型的抗体检测方法及其应用
CN112198319A (zh) * 2020-10-23 2021-01-08 安徽伊普诺康生物技术股份有限公司 一种稳定性增强的人免疫球蛋白g4试剂盒
CN118731344B (zh) * 2024-05-28 2025-12-30 北京华放天实生物制药有限责任公司 一种对双抗生产重组细胞株进行高通量错配检测的方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005249592A (ja) 2004-03-04 2005-09-15 Yamasa Shoyu Co Ltd 遊離ヒトイムノグロブリン軽鎖の測定法及びキット
JP2008528995A (ja) 2005-01-27 2008-07-31 ザ バインディング サイト リミテッド 悪性プラズマ細胞疾患の検出又はモニタリング方法
US20110008806A1 (en) 2008-01-02 2011-01-13 Fundação De Amparoá Pesquisa Do Estado De Minas Gerais - Fapemig Method and kit for quantifying of allergen-specific human igg subclasses for the control and attendance of specific immunotherapy
JP2012050369A (ja) 2010-08-31 2012-03-15 Kanazawa Medical Univ ＩｇＧ４関連疾患診断用マーカー及びその利用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005249592A (ja) 2004-03-04 2005-09-15 Yamasa Shoyu Co Ltd 遊離ヒトイムノグロブリン軽鎖の測定法及びキット
JP2008528995A (ja) 2005-01-27 2008-07-31 ザ バインディング サイト リミテッド 悪性プラズマ細胞疾患の検出又はモニタリング方法
US20110008806A1 (en) 2008-01-02 2011-01-13 Fundação De Amparoá Pesquisa Do Estado De Minas Gerais - Fapemig Method and kit for quantifying of allergen-specific human igg subclasses for the control and attendance of specific immunotherapy
JP2012050369A (ja) 2010-08-31 2012-03-15 Kanazawa Medical Univ ＩｇＧ４関連疾患診断用マーカー及びその利用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Elizabeth Young, Emma Lock, et al.，Estimaton of polyclonal IgG4 hybrids in normal human serum，Immunology，英国，2014年07月10日，vol. 142, no. 3, 406-413
Evgenii A. Lekchnov, Sergey E. Sedykh, et al.，Human placenta: relative content of antibodies of different classes and subclasses (IgG1-IgG4) containing lambda- and kappa-light chains and chimeric lambda-kappa-immunoglobulins，International Immunology，日本，2015年06月01日，Vol. 27, No. 6, pp. 297-306
Mahmud Abo Salook, Carlos Benbassat, et al.，IgG4-related thyroiditis: a case report and review of literature，Endocrinology, Diabetes & Metabolism Case Reports，米国，2014年，2014: 140037
Shapiro RI, Plavina T, et al.，Development and validation of immunoassays to quantify the half-antibody exhange of an IgG4 antibody, natalizumab (Tysabri) with endogenous IgG4，Journal of Pharmaceutical and Biomedical Analyis，米国，2011年04月01日，vol. 55, issue 1, 168-175

Also Published As

Publication number Publication date
GB201511364D0 (en) 2015-08-12
WO2017001841A1 (en) 2017-01-05
JP2018519525A (ja) 2018-07-19
EP3314267A1 (en) 2018-05-02

Similar Documents

Publication Publication Date Title
JP5425063B2 (ja) ＩｇＡ腎症の検査方法及び検出キット
US20110229908A1 (en) Methods and products for measuring free immunoglobulin light chain molecules
US8399207B2 (en) Monoclonal antibodies against osteopontin
JP7020924B2 (ja) ＩｇＧ４κ／λハイブリッド抗体の検出によってＩｇＧ４関連疾患を検出またはモニタリングする方法
JP2010047555A (ja) オクラトキシンに対する抗体、その抗体を用いた親和性カラム、およびオクラトキシンの免疫学的検出用キット
EP2295967A1 (en) IgA NEPHROPATHY DETECTION METHOD AND DETECTION KIT
KR101495225B1 (ko) Ast 양의 측정을 통한 간 질환 진단, 예후 또는 모니터링 키트 및 방법
JP5765635B2 (ja) Ｋｕ８６とその自己抗体との複合体の免疫測定方法、それに用いるキット及びそれを用いた癌判定方法
JP6606552B2 (ja) 特異的に精製された抗プレセプシン抗体
CN105051544B (zh) 小鼠血清中大鼠抗体的特异性检测
WO2018132639A1 (en) Methods and kits for the diagnosis and/or prognosis of ocular cicatricial pemphigoid
JP6667806B2 (ja) 甲状腺刺激ホルモンレセプター抗体アイソタイプ測定を用いたバセドウ病の病態診断キット及びバセドウ病の病態の診断方法
JP5504945B2 (ja) Ｆｔｃｄとその自己抗体との複合体の免疫測定方法、それに用いるキット及びそれを用いた癌判定方法
JP5257788B2 (ja) クラスリン重鎖とその自己抗体との複合体の免疫測定方法、それに用いるキット及びそれを用いた癌判定方法
EP3177312B1 (en) Method and kit for detecting bacterial infection
JP2024060569A (ja) 本態性高血圧症を検出するためのバイオマーカー、それを用いた検出方法及び検出試薬
WO2023132348A1 (ja) 急性呼吸窮迫症候群を診断するための試薬および方法
CN102597772B (zh) 5.9kDa肽的免疫学测定方法
KR20240151234A (ko) 세린 프로테아제의 검출용 또는 측정용 시약
WO2019167935A1 (ja) プレセプシン測定に有用な抗ｃｄ１４抗体の使用
CN114981660A (zh) 用于具有小分子调节剂的il-17靶向接合测定的组合物和方法
HK1150457A (en) Iga nephropathy detection method and detection kit
JP2013541560A (ja) 組成物、抗体、喘息診断方法、及び抗体の調製方法
JP2011247787A (ja) コフィリンとその自己抗体との複合体の免疫測定方法、それに用いるキット及びそれを用いた癌判定方法
JP2003028860A (ja) チトクロムｃ測定によるｓｉｒｓにおける多臓器不全の検査試薬

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190606

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200327

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200421

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200708

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20201020

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210316

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210615

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210915

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220104

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220203

R150 Certificate of patent or registration of utility model

Ref document number: 7020924

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250